Pain in Inflammatory Joint Diseases
RecruitingNCT06718569
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Our primary objective is to better understand the etiology and consequences of chronic paint by using an explorative approach to identify phenotypes and endotypes of patients with inflammatory joint diseases, with a special focus on central sensitization and cognitive functioning as a key element in chronic pain. We will also examine the risk factors and clinical impact of these factors on pain, disease activity and treatment effects in a longitudinal study of patients with inflammatory joint disesases.
Study details
- Official title
- Advancing the Understanding of Pain Mechanisms in Inflammatory Arthritis Towards Precision Pain Management
- Conditions
- Arthritis
- Arthritis, Juvenile Idiopathic
- Arthritis,Rheumatoid
- Arthritis, Reactive
- Arthritis, Psoriatic
- Spondyloarthritis (SpA)
- Interventions
- Drug: Biological or targeted synthetic DMARD
- Sponsor
- Diakonhjemmet Hospital
- Collaborators
- University of Oslo
- Start date
- 2025-11-11
- Primary completion
- 2027-11
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- Norway
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * All patients who initiate or switch biological or targeted synthetic DMARDs Exclusion Criteria: * None
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06718569